Here, we report a biological role for miR-876 in CCA progression, identify BCL-XL as its functional target in established cell lines and in a patient-derived xenograft culture, and suggest a potential therapeutic role. The gene discussed is BCL2L1; the disease is cholangiocarcinoma.